BLFS
Price
$27.36
Change
+$1.25 (+4.79%)
Updated
Dec 20, 04:59 PM (EDT)
81 days until earnings call
CATX
Price
$2.86
Change
+$0.02 (+0.70%)
Updated
Dec 20, 04:59 PM (EDT)
95 days until earnings call
Ad is loading...

BLFS vs CATX

Header iconBLFS vs CATX Comparison
Open Charts BLFS vs CATXBanner chart's image
BioLife Solutions
Price$27.36
Change+$1.25 (+4.79%)
Volume$7.19K
CapitalizationN/A
Perspective Therapeutics
Price$2.86
Change+$0.02 (+0.70%)
Volume$22.59K
CapitalizationN/A
BLFS vs CATX Comparison Chart
Loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CATX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLFS vs. CATX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a Hold and CATX is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (BLFS: $27.39 vs. CATX: $2.85)
Brand notoriety: BLFS and CATX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BLFS: 245% vs. CATX: 168%
Market capitalization -- BLFS: $810.87M vs. CATX: $751.25M
BLFS [@Medical Specialties] is valued at $810.87M. CATX’s [@Medical Specialties] market capitalization is $751.25M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 1 FA rating(s) are green whileCATX’s FA Score has 0 green FA rating(s).

  • BLFS’s FA Score: 1 green, 4 red.
  • CATX’s FA Score: 0 green, 5 red.
According to our system of comparison, BLFS is a better buy in the long-term than CATX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 6 TA indicator(s) are bullish while CATX’s TA Score has 4 bullish TA indicator(s).

  • BLFS’s TA Score: 6 bullish, 3 bearish.
  • CATX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BLFS is a better buy in the short-term than CATX.

Price Growth

BLFS (@Medical Specialties) experienced а +2.58% price change this week, while CATX (@Medical Specialties) price change was -18.10% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.51%. For the same industry, the average monthly price growth was +1.92%, and the average quarterly price growth was +0.64%.

Reported Earning Dates

BLFS is expected to report earnings on Mar 13, 2025.

CATX is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Medical Specialties (-1.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLFS($811M) has a higher market cap than CATX($751M). BLFS YTD gains are higher at: 68.554 vs. CATX (-29.104). CATX has higher annual earnings (EBITDA): -39.08M vs. BLFS (-45.24M). BLFS has more cash in the bank: 51.7M vs. CATX (9.24M). CATX has less debt than BLFS: CATX (2.55M) vs BLFS (42.7M). BLFS has higher revenues than CATX: BLFS (143M) vs CATX (0).
BLFSCATXBLFS / CATX
Capitalization811M751M108%
EBITDA-45.24M-39.08M116%
Gain YTD68.554-29.104-236%
P/E Ratio238.10N/A-
Revenue143M0-
Total Cash51.7M9.24M560%
Total Debt42.7M2.55M1,674%
FUNDAMENTALS RATINGS
BLFS vs CATX: Fundamental Ratings
BLFS
CATX
OUTLOOK RATING
1..100
9416
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
36
Fair valued
PROFIT vs RISK RATING
1..100
74100
SMR RATING
1..100
9395
PRICE GROWTH RATING
1..100
3997
P/E GROWTH RATING
1..100
14100
SEASONALITY SCORE
1..100
2075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CATX's Valuation (36) in the Biotechnology industry is somewhat better than the same rating for BLFS (95) in the Medical Specialties industry. This means that CATX’s stock grew somewhat faster than BLFS’s over the last 12 months.

BLFS's Profit vs Risk Rating (74) in the Medical Specialties industry is in the same range as CATX (100) in the Biotechnology industry. This means that BLFS’s stock grew similarly to CATX’s over the last 12 months.

BLFS's SMR Rating (93) in the Medical Specialties industry is in the same range as CATX (95) in the Biotechnology industry. This means that BLFS’s stock grew similarly to CATX’s over the last 12 months.

BLFS's Price Growth Rating (39) in the Medical Specialties industry is somewhat better than the same rating for CATX (97) in the Biotechnology industry. This means that BLFS’s stock grew somewhat faster than CATX’s over the last 12 months.

BLFS's P/E Growth Rating (14) in the Medical Specialties industry is significantly better than the same rating for CATX (100) in the Biotechnology industry. This means that BLFS’s stock grew significantly faster than CATX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLFSCATX
RSI
ODDS (%)
Bullish Trend 3 days ago
61%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
72%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 10 days ago
79%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Ad is loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CATX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LSHUX34.460.93
+2.77%
Kinetics Spin-Off and Corp Rest Instl
AMADX36.680.38
+1.05%
American Century Discplnd Cor Val A
PJERX13.310.12
+0.91%
PGIM Jennison Global Equity Income R
FTYCX44.140.27
+0.62%
FullerThaler Behavioral Sm-Cp Eq C
PMICX10.690.05
+0.47%
Putnam Multi-Asset Income C

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with MASS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then MASS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
+4.90%
MASS - BLFS
50%
Loosely correlated
+6.19%
RGEN - BLFS
49%
Loosely correlated
-1.42%
VCYT - BLFS
48%
Loosely correlated
+4.66%
AZTA - BLFS
48%
Loosely correlated
+1.88%
RDNT - BLFS
44%
Loosely correlated
+1.85%
More

CATX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CATX has been closely correlated with STRR. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if CATX jumps, then STRR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CATX
1D Price
Change %
CATX100%
+0.35%
STRR - CATX
88%
Closely correlated
-1.82%
ANPCF - CATX
26%
Poorly correlated
N/A
DHR - CATX
26%
Poorly correlated
+1.06%
TMO - CATX
25%
Poorly correlated
+1.42%
BLFS - CATX
24%
Poorly correlated
+4.90%
More